Track topics on Twitter Track topics that are important to you
Nucala is claimed to be the only targeted biologic to secure approval for the condition in the six to 11-year age group in the US. The FDA approval
The post FDA approves GSK’s Nucala for young children with severe eosinophilic asthma appeared first on Pharmaceutical Business review.NEXT ARTICLE
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...